Amgen (NASDAQ:AMGN) announced today that Repatha® (evolocumab), when added to statins or other low-density lipoprotein cholesterol (LDL-C)-lowering treatments, reduced the risk of first major adverse ...

Evolocumab (Repatha) reduced risk of a first major cardiovascular (CV) event in patients with diabetes but no known atherosclerosis in a substudy of the VESALIUS-CV trial. The PCSK9 inhibitor cut ...

New-onset vitreous floaters, with or without flashes, confer an increased risk for retinal detachment (RD), according to a study published in the March issue of the Annals of Family Medicine.

Women who consistently met physical activity guidelines throughout middle age had half the risk of dying from any cause ...

Clinicians were hesitant to prescribe central nervous system stimulants for young adults with ADHD and co-occurring substance use disorder.

HRD-positive tumors derived the largest median PFS gain with rucaparib maintenance versus placebo, consistent with PARP ...

A new systematic review and meta-analysis suggests that nerandomilast (Jascayd; Boehringer Ingelheim), an oral therapy for ...

Central banks are adopting a firmer tone once more, and financial / crypto markets are responding with notable intensity : CoinShares.

Dry conditions are persisting as drought continues to expand across the region with the lack of rainfall in Siouxland.

Higher meat intake was linked to lower dementia risk in APOE4 carriers but no other groups, highlighting the potential for ...

Long-term underperformance versus peers like VTV is likely due to higher fees and less pure value exposure. See more.

Objectives To assess the association between epidural analgesia (EDA) experience and subsequent fertility intention among ...